Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arturo Macarrón

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Genome Editing|February 16, 2024
Revolutionizing <i>in vivo</i> therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challengesArturo Macarrón Palacios, Patrick Korus, Bodo G C Wilkens, et al.
RSC Advances|December 12, 2022
Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminaseAdem Hadjabdelhafid-Parisien, Sebastian Bitsch, Arturo Macarrón Palacios, et al.
Chembiochem : a European Journal of Chemical Biology|June 18, 2019
TRAIL-Inspired Multivalent Dextran Conjugates Efficiently Induce Apoptosis upon DR5 Receptor ClusteringHendrik Schneider, Desislava Yanakieva, Arturo Macarrón, et al.
Frontiers in Chemistry|August 9, 2021
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation <i>In Vitro</i>Hendrik Schneider, Simon Englert, Arturo Macarrón Palacios, et al.
Frontiers in Immunology|December 16, 2020
Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark AntibodiesArturo Macarrón Palacios, Julius Grzeschik, Lukas Deweid, et al.
Biotechnology Journal|October 20, 2020
Humanization of Chicken-Derived scFv Using Yeast Surface Display and NGS Data MiningAdrian Elter, Jan P Bogen, Steffen C Hinz, et al.
Frontiers in Genome Editing|October 29, 2024
Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenesNajmeh Heshmatpour, S Maryam Kazemi, Niklas D Schmidt, et al.
Angewandte Chemie (International Ed. in English)|September 1, 2022
Sactipeptide Engineering by Probing the Substrate Tolerance of a Thioether-Bond-Forming SactisynthaseAtaurehman Ali, Dominic Happel, Jan Habermann, et al.
Frontiers in Immunology|September 13, 2024
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignanciesJordi Pfeifer Serrahima, Katrin Schoenfeld, Ines Kühnel, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 18, 2021
Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoesBastian Becker, Simon Englert, Hendrik Schneider, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Genome Editing|February 16, 2024
Revolutionizing <i>in vivo</i> therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challengesArturo Macarrón Palacios, Patrick Korus, Bodo G C Wilkens, et al.
RSC Advances|December 12, 2022
Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminaseAdem Hadjabdelhafid-Parisien, Sebastian Bitsch, Arturo Macarrón Palacios, et al.
Chembiochem : a European Journal of Chemical Biology|June 18, 2019
TRAIL-Inspired Multivalent Dextran Conjugates Efficiently Induce Apoptosis upon DR5 Receptor ClusteringHendrik Schneider, Desislava Yanakieva, Arturo Macarrón, et al.
Frontiers in Chemistry|August 9, 2021
Synthetic Integrin-Targeting Dextran-Fc Hybrids Efficiently Inhibit Tumor Proliferation <i>In Vitro</i>Hendrik Schneider, Simon Englert, Arturo Macarrón Palacios, et al.
Frontiers in Immunology|December 16, 2020
Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark AntibodiesArturo Macarrón Palacios, Julius Grzeschik, Lukas Deweid, et al.
Biotechnology Journal|October 20, 2020
Humanization of Chicken-Derived scFv Using Yeast Surface Display and NGS Data MiningAdrian Elter, Jan P Bogen, Steffen C Hinz, et al.
Frontiers in Genome Editing|October 29, 2024
Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenesNajmeh Heshmatpour, S Maryam Kazemi, Niklas D Schmidt, et al.
Angewandte Chemie (International Ed. in English)|September 1, 2022
Sactipeptide Engineering by Probing the Substrate Tolerance of a Thioether-Bond-Forming SactisynthaseAtaurehman Ali, Dominic Happel, Jan Habermann, et al.
Frontiers in Immunology|September 13, 2024
Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignanciesJordi Pfeifer Serrahima, Katrin Schoenfeld, Ines Kühnel, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 18, 2021
Multivalent dextran hybrids for efficient cytosolic delivery of biomolecular cargoesBastian Becker, Simon Englert, Hendrik Schneider, et al.
Pageof 2